{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-024751","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.560972+00:00","generated_at":"2026-06-19T02:35:11.185855+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aclaris Therapeutics enters $200M ATM equity facility, terminates prior $150M ATM","bullets":["New Sales Agreement with SVB Securities and Cantor Fitzgerald for up to $200M in common stock at-the-market.","Prior $150M ATM terminated; $72.7M net proceeds raised from 4.8M shares under prior agreement.","Commission of 3% of gross proceeds on sales under new agreement.","Company not obligated to sell any shares; offering at its sole discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-024751","json":"https://secwatch.observer/filing/0001104659-23-024751.json","markdown":"https://secwatch.observer/filing/0001104659-23-024751.md","text":"https://secwatch.observer/filing/0001104659-23-024751.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000110465923024751/0001104659-23-024751-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000110465923024751/tm237408d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T02:35:11.185855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}